Resultado de búsqueda
WHO Programme for International Drug Monitoring. A vital, global collaboration to protect patients from the harm that medicines can cause
- Pharmacovigilance Communications
Uppsala Monitoring Centre strives to meet a global need for...
- Research
At UMC we work to develop the best possible tools for...
- WHODrug User Area
We can't sign you in. Your browser is currently set to block...
- WHODrug Subscription
You will then be contacted by a UMC staff member to discuss...
- VigiLyze
VigiLyze supports the entire signal detection and management...
- VigiBase Services
VigiBase is at the heart of UMC ’ s signal detection and...
- Self-paced online courses
Uppsala Monitoring Centre offers a range of self-paced...
- About Uppsala Monitoring Centre
Uppsala Monitoring Centre advances the science of...
- Pharmacovigilance Communications
Your knowledge centre for medicines safety. Together with its partners, Uppsala Monitoring Centre offers a range of learning programmes and resources that support the safer use of medicines. Our instructor-led and self-paced online courses provide national centres and regulatory bodies with the technical know-how and skills to strengthen their ...
Uppsala Monitoring Centre (UMC), located in Uppsala, Sweden, is the field name for the World Health Organization Collaborating Centre for International Drug Monitoring. UMC works by collecting, assessing and communicating information from member countries' national pharmacovigilance centres in regard to the benefits, harm ...
17 de abr. de 2024 · Uppsala Monitoring Centre is a non-profit foundation for safer use of medicines and vaccines and the designated WHO Collaborating Centre for International Drug Monitoring. UMC works to connect pharmacovigilance stakeholders across the world.
Hace 6 días · About Uppsala Monitoring Centre Board. UMC’s board members. UMC’s board consists of six members and their alternates, appointed by WHO and by the Swedish government. The operations of UMC as a WHO Collaborating Centre are governed by an agreement between WHO Headquarters and the Swedish government.